Carboplatin and etoposide followed by once-daily thoracic radiotherapy in limited disease small-cell lung cancer: Unsatisfactory results

Tumori

Volumn 96, Issue 2, 2010, Pages 234-240

  Yilmaz, Ufuk ^a   Anar, Ceyda ^a   Korkmaz, Esra ^a   Yapicioglu, Sena ^a   Karadogan, Ilker ^a   Ozkök, Serdar ^b  

^a Department of Pulmonary Medicine   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Cancer; Carboplatin; Radiotherapy; Survival

Indexed keywords

CARBOPLATIN; CREATININE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; NITROGEN; SEROTONIN 3 ANTAGONIST; STEROID; UREA;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BACTERIAL PNEUMONIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOPENIA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; OBSERVATIONAL STUDY; ORAL MUCOSAL DISEASE; OVERALL SURVIVAL; PLEURA EFFUSION; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; SEPSIS; SIDE EFFECT; SKULL IRRADIATION; SUPRACLAVICULAR LYMPH NODE METASTASIS; SURVIVAL TIME; THORAX; THROMBOCYTOPENIA; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL;

EID: 77952938727     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600208     Document Type: Article

References (25)

1. El Maalouf G, Rodier JM, Faivre S, Raymond E: Could we expect to improve survival in small cell lung cancer? Lung Cancer, 57: 30-34, 2007.
2. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B: A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Eng J Med, 327: 1618-1624, 1992.
3. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol, 10: 890-895, 1992.
4. Janne PA, Freidlin P, Saxman S: Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America. Cancer, 95: 1528-1538, 2002.
5. De Ruysscher D, Vansteenkiste J: Chest radiotherapy in limited-stage small cell lung cancer: facts, question, prospects. Radiother Oncol, 55: 1-9, 2000. (Pubitemid 30219428)
6. Fried DB, Morris DE, Poole C, Rosenman JG, Halle JS, Detterbeck FC, Hensing TA, Socinski MA: Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol, 22: 4837-4845, 2004.
7. De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P: Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol, 17: 543-552, 2006.
8. Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK: Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol, 24: 3823-3830, 2006. (Pubitemid 46630728)
9. Skarlos DV, Samantas E, Kosmidis P, Fauntzilas G, Angelidou M, Palamidas PH, Mylonakis N, Provata A, Papadakis E, Klouvas G, Theocharis D, Panousaki E, Boleti F, Sphakianoudis G, Pavlidis N and the Lung Cancer Study Group: Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. Hellenic Co-operative Oncology Group study. Ann Oncol, 5: 601-607, 1994.
10. Lokich J, Anderson N: Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol, 9: 13-21, 1998. (Pubitemid 28125759)
11. Lassen U, Kristjansen PEG, Osterlind K, Bergman B, Sigsgaard TC, Hirsch FR, Hansen M, Dombernowsky P, Hansen HH: Superiority of cisplatin or carboplatin in combination with teniposide and vincristin in the induction chemotherapy of small-cell lung cancer. A randomized trial with five years follow-up. Ann Oncol, 7: 365-371, 1996.
12. Jezdic S, Jelic S, Radosavlijevic D, Kezic I: Cisplatin or carboplatin-based regimens for small-cell lung cancer - a randomized phase III study. Lung Cancer, 49 (suppl 2): 322, 2005.
13. Spigel DR, Hainsworth JD, Burris HA: Long-term follow-up of limited stage small cell lung cancer patients treated with carboplatin-based therapy and radiotherapy by the Minnie Pearl cancer Research Network (MPCRN). Proc ASCO, 22: 7222, 2004.
14. Smith IE, Evans BD, Gore ME, Vincent MD, Repetto L, Yarnold JR: Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first line combination therapy for small cell lung cancer. J Clin Oncol, 5: 185-189, 1987.
15. Stahel RA, Ginsberg R, Havemann K, Hirsch FR, Ihde DC, Jassem J, Karrer K, Maurer LH, Osterlind K, Van Houtteet P: Staging and prognostic factors in small cell lung cancer; a consensus report. Lung Cancer, 5: 119-126, 1989. (Pubitemid 20053516)
16. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer, 47: 207-214, 1981.
17. Zelen M: Keynote address on biostatistics and data retrieval. Cancer Chemother Rep, 4: 31-42, 1973.
18. Micke P, Faldum A, Metz T, Beeh KM, Bittinger F, Hengstler JG, Buhl R: Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer -What limits limited disease? Lung Cancer, 37: 271-276, 2002.
19. Ignatius Ou SH, Zell JA: The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM edition. J Thorac Oncol, 4: 300-310, 2009.
20. Laly BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC: Small cell lung cancer: Have we made any progress over the last 25 years? Oncologist, 12: 1096-1104, 2007.
21. Turrisi AT 3rd, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, Wagner H, Aisner S, Johnson DH: Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med, 340: 265-271, 1999. (Pubitemid 29063268)
22. Takada M, Fukuoka M, Kawahara M, Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol, 20: 3054-3060, 2002. (Pubitemid 34791094)
23. Skarlos DV, Samantas E, Briassoulis E, Panoussaki E, Pavlidis N, Kalofonos HP, Kardamakis D, Tsiakopoulos E, Kosmidis P, Tsavdaridis D, Tzitzikas J, Tsekeris P, Kouvatseas G, Zamboglou N, Fountzilas G: A randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol, 12: 1231-1238, 2001.
24. Jeremic B, Shibamoto Y, Acimovic L, Milsavljevic S: Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol, 15: 893-900, 1997. (Pubitemid 27106269)
25. Manapov F, Klautke G, Fietkau R: Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thorac Oncol, 3: 652-655, 2008. (Pubitemid 351787312)